Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (264) Arrow Down
Filter Results: (264) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (264)
    • News  (111)
    • Research  (113)
    • Events  (1)
    • Multimedia  (3)
  • Faculty Publications  (39)

Show Results For

  • All HBS Web  (264)
    • News  (111)
    • Research  (113)
    • Events  (1)
    • Multimedia  (3)
  • Faculty Publications  (39)
← Page 5 of 264 Results →
  • 22 Feb 2022
  • Research & Ideas

Lack of Female Scientists Means Fewer Medical Treatments for Women

Women are more likely to invent medical treatments for endometriosis, cervical cancer, and other female conditions, but the dearth of women scientists limits the potential for such life-saving innovations. Female research teams are 35... View Details
Keywords: by Kristen Senz

    Malcolm S. Salter

    Malcolm Salter has been a member of the Harvard Business School faculty since 1967. His teaching and research focus on issues of corporate strategy, organization, and governance.

    In addition to teaching at HBS, he has held faculty positions at the Harvard... View Details

    Keywords: arts; automobiles; energy; investment banking industry; retailing; venture capital industry
    • March 2021 (Revised January 2023)
    • Case

    The Trouble with TCE

    By: Vincent Pons, Rafael Di Tella and Galit Goldstein
    Trichloroethylene, or TCE, was a chemical used by tens of thousands of businesses in the United States. It was an affordable tool for many. Yet, TCE had been associated with important health risks, including cancer and autoimmune disease. TCE potentially posed other... View Details
    Keywords: Trichloroethylene; Toxicity; Lobbying; Chemicals; Health Disorders; Governing Rules, Regulations, and Reforms; Policy; Ethics; Business and Government Relations; Chemical Industry; United States
    Citation
    Educators
    Purchase
    Related
    Pons, Vincent, Rafael Di Tella, and Galit Goldstein. "The Trouble with TCE." Harvard Business School Case 721-031, March 2021. (Revised January 2023.)
    • 30 Nov 2016
    • HBS Seminar

    Melissa Valentine and Michael Bernstein, Stanford University

    • 16 Sep 2019
    • Research & Ideas

    Crowdsourcing Is Helping Hollywood Reduce the Risk of Movie-Making

    writer based in the Boston area. [Image: CasarsaGuru] Related Reading: Related Reading Black Business Leaders Series: Franklin Leonard, 'Black List' Mastermind Should Entrepreneurs Pitch Products or Ideas for Products? Open Innovation Contestants Build AI-Based View Details
    Keywords: by Michael Blanding; Motion Pictures & Video
    • Web

    Faculty & Advisors | MBA

    she started her career as an analyst at MPM. She currently serves on the Harvard Medical School Board of Fellows and is a Trustee of the American Association for Cancer Research Foundation. Enke Bashllari... View Details
    • January 2023
    • Case

    Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery

    By: Regina Herzlinger and Brian Walker
    What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
    Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
    Citation
    Educators
    Purchase
    Related
    Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
    • March 2008 (Revised June 2008)
    • Case

    The Broad Institute: Applying the Power of Genomics to Medicine

    By: Vicki L. Sato and Rachel Gordon
    In June 2003, Harvard University and MIT announced an unprecedented partnership to create a biomedical institute, The Broad Institute. The culture of the Broad centered on science, and those involved considered it to be at the edge of the scientific frontier. In just... View Details
    Keywords: Education; Health Care and Treatment; Innovation Leadership; Growth and Development Strategy; Organizational Culture; Partners and Partnerships; Research and Development; Genetics
    Citation
    Educators
    Purchase
    Related
    Sato, Vicki L., and Rachel Gordon. "The Broad Institute: Applying the Power of Genomics to Medicine." Harvard Business School Case 608-114, March 2008. (Revised June 2008.)
    • Web

    Value-Based Health Care - Institute For Strategy And Competitiveness

    HBS ISC Health Care Health Care Value-Based Health Care Health Care Courses Fast Facts Value-Based Health Care Value-Based Health Care Cases & Teaching Notes Key Concepts Key Stakeholders Publications Team Work With Us Presentations Value-Based Health Care Based on the... View Details
    • 12 Dec 2022
    • Research & Ideas

    Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them

    Black patients and their doctors may be more open to new medications if drug trials included more Black people, new research shows. Currently, Black Americans represent just 5 percent of drug trial participants. Nearly three-quarters of... View Details
    Keywords: by Scott Van Voorhis; Pharmaceutical; Health
    • Web

    Hiring Organizations

    Benchstrength Berkeley Research Group LLC Berkshire Partners BHP Biogen BJ's Wholesale Club Blackhorn Ventures BlackRock Blackstone Blank Street Blitzy AI Bloomberg Center for Cities at Harvard University Bloomberg Harvard City Leadership... View Details
    • 14 Dec 2020
    • Research & Ideas

    What Does December's Drug-Approval Dash Mean for COVID-19 Vaccines?

    Pharmaceutical regulators around the world tend to speed through drug applications in December and before major national holidays, according to new research that might raise questions about COVID-19 vaccines and other treatments under... View Details
    Keywords: by Danielle Kost; Pharmaceutical; Health
    • 01 Jun 2009
    • Lessons from the Classroom

    The Challenges of Investing in Science-Based Innovation

    In economic downtimes, businesses are apt to cut R&D projects that don't promise a speedy return on investment. But take a cue from smart science-based businesses, which view the recession as an opportunity to stoke up research and... View Details
    Keywords: by Julia Hanna; Banking; Auto; Pharmaceutical
    • Web

    Blavatnik Fellowship in Life Science Entrepreneurship - Health Care

    offers Harvard Business School (HBS) alumni and Harvard-affiliated postdoctoral researchers the opportunity to advance new ventures around promising life science technologies and develop their leadership talents during a 12-month... View Details
    • 30 Apr 2024
    • Book

    When Managers Set Unrealistic Expectations, Employees Cut Ethical Corners

    In the 1990s, when Harvard Business School Professor Lynn S. Paine was researching and writing about examples of corporate misconduct, she hoped more businesses would take decisive action to root out fraud and other unethical behavior.... View Details
    Keywords: by Dina Gerdeman
    • 14 Jul 2009
    • First Look

    First Look: July 14

    innovation in which an innovator uses several research inputs to invent a new good. These inputs, in turn, must be invented before they can be used by the final innovator. As a consequence, the degree of patent protection affects the... View Details
    Keywords: Martha Lagace
    • 01 Sep 2015
    • First Look

    First Look -- September 1, 2015

    https://www.hbs.edu/faculty/Pages/item.aspx?num=49520 2015 Journal of Comparative Effectiveness Research Comparative Costs of Advanced Proton and Photon Radiation Therapies: Lessons from Time-driven Activity-based Costing in Head and Neck... View Details
    Keywords: Sean Silverthorne
    • 20 Sep 2016
    • First Look

    September 20, 2016

    growing body of research yields ample evidence that individuals’ behavior often reflects an apparent concern for moral considerations. Using a broad definition of morality—to include varied non-egoistic motivations such as fairness,... View Details
    Keywords: Sean Silverthorne
    • Web

    Organize Care Around Medical Conditions - Institute For Strategy And Competitiveness

    teams and services that all manage aspects of breast cancer over the full cycle of care. This would be surgical oncologists, medical oncologists, radiation oncologists, reconstructive surgeons, pathologists, and radiologists. Specialized... View Details
    • 03 Oct 2023
    • Research Event

    Build the Life You Want: Arthur Brooks and Oprah Winfrey Share Happiness Tips

    specifically his descriptions of the manifold research that's going on on happiness, did you yourself change your own definition of what happiness is? What did you what did you learn or change? Winfrey: What I learned is that days where... View Details
    Keywords: by HBS Staff
    • ←
    • 5
    • 6
    • …
    • 13
    • 14
    • →
    ǁ
    Campus Map
    Harvard Business School
    Soldiers Field
    Boston, MA 02163
    →Map & Directions
    →More Contact Information
    • Make a Gift
    • Site Map
    • Jobs
    • Harvard University
    • Trademarks
    • Policies
    • Accessibility
    • Digital Accessibility
    Copyright © President & Fellows of Harvard College.